Loading

Virpax Pharmaceuticals, Inc.

June 03, 2024
Company Presentation
Pain Management
Company Presentation Theater 3
Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications.
Virpax Pharmaceuticals, Inc.
Company Website: https://virpaxpharma.com/
Lead Product in Development: Probudur- A next generation liposomal bupivacaine formulation that has demonstrated 96 hours pain control after administering a single injection at the wound site in animal studies.
Number Of Unlicensed Products (For Which You Are Seeking Partners): 5

Exchange

NASDAQ

Ticker

VRPX

Company HQ City

Berwyn

Company HQ State

PA

Company HQ Country

United States

CEO/Top Company Official

Gerald W. Bruce

Development Phase of Primary Product

Pre-Clinical
Speakers
Gerald Bruce, BA
Chief Executive Officer
Virpax Pharmaceuticals Inc.
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS